Table 4.
Preoperative (n=45) | 3 months postoperative (n=45) | |
---|---|---|
| ||
IPSS * | ||
Mean (SD) | 18.1/35 (7.6/35) | 6.7/35 (4.3/35) |
Median | 19.0/35 | 6.0/35 |
Range | (0/35–30/35) | (0/35–18/35) |
Change from baseline (SD) | – | −11.3 (8.2) |
| ||
IPSS quality of life * | ||
Mean (SD) | 4.5/6 (1.6/6) | 1.7/6 (1.8/6) |
Median | 4.5/6 | 1.0/6 |
Range | (0/6–6/6) | (0/6–6/6) |
Change from baseline (SD) | – | −2.7 (2.3) |
| ||
Postvoid residual volume (ml) * | ||
Mean (SD) | 219.1 (148.9) | 75.0 (71.3) |
Median | 167.0 | 44.0 |
Range | (60.0–600.0) | (0–259.0) |
Change from baseline (SD)* | – | −177.4 (147.5) |
| ||
Qmax (mL/second) ** | ||
Mean (SD) | 4.1 (6.5) | 19.8 (11.2) |
Median | 0.0 | 17.0 |
Range | (0.0–36.0) | (3.5–49.0) |
Change from baseline (SD)* | – | +16.0 (12.5) |
| ||
Catheter or self-catheterization-dependent, n (%) | 35 (67.3) | 2 (3.8) |
Only applies to patients non-catheter or self-catheterization-dependent.
Patients who were catheter or self-catheterization-dependent were considered to have a Qmax of 0.
IPSS: International Prostate Symptom Score; SD: standard deviation; Qmax: maximum urinary flow rate.